Updated:
Ventyx Biosciences, Inc.
Ventyx Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001851194, and its reported...
Overview
Ventyx Biosciences, Inc. is identified in the retained SEC EDGAR snapshot dated 2026-10-14. Its SEC Central Index Key is 0001851194, and its reported industry is Pharmaceutical Preparations. In 10-K filed on 2025-02-27, it reported net income of USD -135,122,000; total assets of USD 276,563,000 for the fiscal period ended 2024-12-31. The financial history preserves reporting periods, currencies, filing accessions and source provenance. Figures are reported filing data, rather than real-time estimates.
Company overview
- Legal name
- Ventyx Biosciences, Inc.
- Classification
- Company
- Industry (SIC)
- 2834 — Pharmaceutical Preparations
- Headquarters
- San Diego, CA, United States
- Incorporated in
- DE
- Fiscal year end
- December 31
- SEC CIK
- 0001851194
Financials
Annual figures as originally reported. Currency is shown for each fiscal year; B means billion and M means million.
| Fiscal year | Period end | Net income | Total assets | Cash and equivalents | Operating cash flow |
|---|---|---|---|---|---|
| FY2024USD | -$135.1M | $276.6M | $27.3M | -$130.9M | |
| FY2023USD | -$193.0M | $277.7M | $51.6M | -$166.5M | |
| FY2022USD | -$108.4M | $371.4M | $64.8M | -$98.8M | |
| FY2021USD | -$83.7M | $291.5M | $70.8M | -$38.6M |
Recent SEC filings
| Form | Filed | Period | Filing |
|---|---|---|---|
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 10-Q | 10-Q | ||
| 8-K | 8-K | ||
| 8-K | 8-K | ||
| 8-K | 8-K |
Profile maintained by Altss. Updated: . To correct this record or make a privacy request, send the page URL and your evidence to privacy@altss.com; corrections are free.
Research Ventyx Biosciences, Inc. in Altss
Track this company’s investors, transactions and relationships in Altss.